NEW YORK (Reuters) - Shares of Human Genome soared 232 percent to $11.03 in premarket trading on Monday, after the company released positive results for a drug designed to treat lupus.
(Reporting by Ryan Vlastelica; Editing by Theodore d'Afflisio)
KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed a combination of "human and systemic failures" for allowing the botched Christmas Day attack aboard a Detroit-bound U.S. airliner, in his first big test on homeland security. | Video
Rust-belt American cities like Youngstown, Ohio were battered by the downturn. Now they're ready to move on, but it won’t be easy. The first in a three-part report. Full Article
Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too. Commentary
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
